Kent Lake Capital’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$3.13M Buy
1,738,102
+716,951
+70% +$2.07M 1.41% 28
2024
Q1
$4.86M Sell
1,021,151
-94,890
-9% -$333K 2.12% 21
2023
Q4
$3.24M Sell
1,116,041
-1,213,246
-52% -$1.91M 1.25% 28
2023
Q3
$3.14M Buy
2,329,287
+1,622,938
+230% +$2.84M 1.21% 30
2023
Q2
$1.52M Sell
706,349
-138,226
-16% -$335K 0.7% 36
2023
Q1
$2.46M Sell
844,575
-255,425
-23% -$1.29M 1.66% 23
2022
Q4
$7.56M Buy
1,100,000
+716,304
+187% +$3.38M 4.52% 9
2022
Q3
$1.22M Buy
+383,696
New +$1.39M 0.8% 30
2021
Q4
Sell
-930,709
Closed -$6.11M 49
2021
Q3
$6.11M Sell
930,709
-209,144
-18% -$2.01M 2.63% 17
2021
Q2
$18.3M Sell
1,139,853
-66,829
-6% -$923K 6.99% 4
2021
Q1
$14.9M Sell
1,206,682
-35,318
-3% -$541K 6.07% 5
2020
Q4
$13.8M Buy
+1,242,000
New +$9.33M 6.53% 5

Other funds holding STIM

Kent Lake Capital's STIM Position: Q2 2024 in Review

Kent Lake Capital increased its Neuronetics (STIM) stake by 70% in Q2 2024, buying an estimated $2.07M and bringing the position to 1,738,102 shares worth $3.13M. The position accounts for 1.41% of the portfolio, ranked #28.

Kent Lake Capital first reported a position in STIM in Q4 2020 and has held it in 12 quarters since. The position peaked at $18.3M in Q2 2021. 67 funds tracked by Wall St. Rank hold STIM as of Q2 2024.

  • Kent Lake Capital held 1,738,102 shares of Neuronetics worth $3.13M as of Q2 2024.
  • Kent Lake Capital bought 716,951 Neuronetics shares in Q2 2024, an estimated $2.07M.
  • Neuronetics made up 1.41% of Kent Lake Capital's portfolio in Q2 2024, its #28 holding.
  • Kent Lake Capital first reported a position in Neuronetics in Q4 2020 and has held it in 12 quarters since.
  • Kent Lake Capital's Neuronetics position peaked at $18.3M in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Neuronetics as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.